Selenium in Treating Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00752739

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00752739. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Chemoprevention Trial of Selenium and Prostate Cancer (Watchful Waiting With Selenium Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Selenium may prevent or slow the growth of prostate cancer. PURPOSE: This randomized phase II trial is studying how well selenium works in treating patients with prostate cancer.

Study identification

NCT ID: NCT00752739
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: University of Arizona; Other
Enrollment: 220 participants

Conditions and interventions

Conditions

Prostate Cancer

Interventions

selenium Dietary Supplement
placebo Other

Dietary Supplement · Other

Eligibility (public fields only)

Age range: Up to 85 Years
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2002 (Type not available)
Primary completion: Apr 2007 (Actual)
Completion: Apr 2007 (Actual)
Last update posted: Aug 15, 2012

2002 – 2007

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Arizona Cancer Center at University of Arizona Health Sciences Center	Tucson	Arizona	85724	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00752739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 15, 2012 · Synced Nov 12, 2026